Jane A. Mitchell
- Biochemistry top 0.02%
- Eicosanoids and Hypertension Pharmacology 77
- Pharmacology top 0.05%
- Inflammatory mediators and NSAID effects 91
- Physiology top 0.1%
- Nitric Oxide and Endothelin Effects 83
- Asthma and respiratory diseases 20
-
- Antiplatelet Therapy and Cardiovascular Diseases 31
- Immunology top 0.5%
- Immune Response and Inflammation 24
-
- Pulmonary Hypertension Research and Treatments 31
-
- Estrogen and related hormone effects 17
- Co-authors
- Timothy D. WarnerJohn R. VaneChristoph ThiemermannFerid MuradPravit AkarasereenontDavid Bishop‐BaileyUlrich FörstermannIvana Vojnovic
- Cited by
- BiochemistryPharmacologyPhysiology
- Journals
- British Journal of Pharmacology (37 papers)The FASEB Journal (21 papers)European Journal of Pharmacology (14 papers)
- Partner nations
- United KingdomUnited StatesQatar
In The Last Decade
Jane A. Mitchell
263 papers receiving 18.5k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Biochemistry 3.0k
- Pharmacology 5.4k
- Physiology 5.9k
- Cardiology and Cardiovascular Medicine 2.9k
- Immunology 2.6k
Countries citing papers authored by Jane A. Mitchell
This map shows the geographic impact of Jane A. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane A. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane A. Mitchell more than expected).
Fields of papers citing papers by Jane A. Mitchell
This network shows the impact of papers produced by Jane A. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane A. Mitchell. The network helps show where Jane A. Mitchell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jane A. Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 30 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 15 | |
| 12 | 2020 | 20 | |
| 13 | 2019 | 156 | |
| 14 | 2018 | 154 | |
| 15 | Abstract 16362: The Right Heart is Specifically Targeted by Intravenous Administration of Treprostinil: Implications for Our Understanding of How Prostacyclin Drugs Work to Treat Pulmonary Arterial Hypertension | 2018 | 1 |
| 16 | Abstract 18520: Novel Tissue-specific Cyclooxygenase-1 Knockout Mice Demonstrate a Dominant Role for Endothelial Cyclooxygenase-1 in Prostacyclin Production | 2017 | 1 |
| 17 | 2013 | 44 | |
| 18 | 2012 | 18 | |
| 19 | 1997 | 75 | |
| 20 | 1997 | 22 |
About Jane A. Mitchell
Jane A. Mitchell is a scholar working on Biochemistry, Pharmacology and Physiology, having authored 268 papers that have together received 19.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (91 papers), Nitric Oxide and Endothelin Effects (83 papers), Eicosanoids and Hypertension Pharmacology (77 papers), Antiplatelet Therapy and Cardiovascular Diseases (31 papers), Pulmonary Hypertension Research and Treatments (31 papers), Immune Response and Inflammation (24 papers), Asthma and respiratory diseases (20 papers) and Estrogen and related hormone effects (17 papers). The work is most often cited by research in Biochemistry (3.0k citations), Pharmacology (5.4k citations) and Physiology (5.9k citations). Jane A. Mitchell has collaborated with scholars based in United Kingdom, United States and Qatar. Frequent co-authors include Timothy D. Warner, John R. Vane, Christoph Thiemermann, Ferid Murad, Pravit Akarasereenont, David Bishop‐Bailey, Ulrich Förstermann, Ivana Vojnovic, Masaki Nakane and R.J. Flower. Their work appears in journals such as British Journal of Pharmacology, The FASEB Journal, European Journal of Pharmacology, PLoS ONE and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.